WebJob posted 18 hours ago - Dyne Therapeutics, Inc. is hiring now for a Full-Time Director, Neuromuscular Research in Waltham, MA. Apply today at CareerBuilder! Web19 hours ago · Here's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now 12/09/22-8:55AM EST Zacks. Other News for DYN Dyne Therapeutics management to meet with Oppenheimer
Did you know?
WebApr 11, 2024 · Dyne Therapeutics, Inc, a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as … WebApr 10, 2024 · Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as …
WebJul 5, 2024 · WALTHAM, Mass., July 05, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for ...
WebApr 11, 2024 · A high-level overview of Dyne Therapeutics, Inc. (DYN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebJan 18, 2024 · Dyne received a clinical hold letter from the FDA on Friday, January 14, 2024 requesting additional clinical and non-clinical information for DYNE-251. The Company …
WebOct 31, 2024 · WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has …
WebApr 13, 2024 · What's Happening With Dyne Therapeutics Inc Stock Today? Dyne Therapeutics Inc (DYN) stock is trading at $8.97 as of 3:43 PM on Thursday, Apr 13, a … open mri johnstown paWebJan 18, 2024 · WALTHAM, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living ... open mri lebanon new hampshireWebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of … open mri locations in columbia mdWebApr 11, 2024 · Dyne Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.63 on … open mri in westmoreland county paWebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. open mri locations in ctWebMar 31, 2024 · Presently, Dyne Therapeutics Inc. shares are logging -25.91% during the 52-week period from high price, and 169.30% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.30 and $15.63. ip address showing different locationWebDec 2, 2024 · Dyne Therapeutics announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a … open mri lawrenceville ga